Rick Doblin, Ph.D., of MAPS Profile Banner
Rick Doblin, Ph.D., of MAPS Profile
Rick Doblin, Ph.D., of MAPS

@RickDoblin

Followers
58,849
Following
3
Media
93
Statuses
1,216

Founder and President of the Multidisciplinary Association for Psychedelic Studies ( @MAPS ) • Account managed by @MAPS

Boston, Massachusetts
Joined February 2010
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
It’s with an enormous sense of pride, satisfaction, and relief that I can share that @MAPS learned that the first of two Phase 3 studies of MDMA-assisted psychotherapy for PTSD was statistically significant and is considered a successful Phase 3 study:
Tweet media one
31
243
921
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
35 years ago today, I founded the Multidisciplinary Association for Psychedelic Studies ( @MAPS ). Happy 35th anniversary, MAPS!
21
72
563
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
Some days I wake up and can’t believe how far we’ve come. Today, @MAPS is featured on the front page of The New York Times ( @NYTimes )!
@MAPS
MAPS
3 years
On the front page of today's @NYTimes , @AndrewJacobsNYT profiles MAPS Founder @RickDoblin , Ph.D., and highlights the success of MAPS' first Phase 3 study of MDMA-assisted therapy for PTSD, the results of which were published in @NatureMedicine today.
Tweet media one
0
73
285
23
86
522
@RickDoblin
Rick Doblin, Ph.D., of MAPS
5 years
I am thrilled to announce that the recording of my Ted Talk about psychedelic research is now available! On the main stage at TED2019, I spoke on how psychedelics can shift the field of mental health and MAPS’ MDMA-assisted psychotherapy research.
18
183
492
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
My 4th appearance on the @JoeRogan Experience was just released—check it out! #JRE Thanks to Joe for hosting me and bringing visibility to @MAPS at such a critical moment in the #psychedelic movement.
Tweet media one
50
68
466
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
Today, The @Guardian published my op-ed outlining why @MAPS envisions a day when psychedelics will be more than a last-ditch treatment: they will be a catalyst for mass mental health.
9
132
462
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
100,000 is a very large number of therapists, but considering the millions of people with PTSD and depression, it’s not unreasonable. @MAPS aims to train 25,000 therapists in MDMA-assisted therapy for PTSD by 2030. @LAWeekly @Berkeley_Psyche @MichaelPollan
17
90
458
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
We are delighted to see legal access to psychedelics for spiritual, health, or personal growth join cannabis reform as a popular and bipartisan issue despite the barriers imposed by antiquated drug policies.
@MAPS
MAPS
4 years
MAPS releases a public statement following the passage of all nine statewide ballot measures to reform #drug policies across the #UnitedStates , including the first measure to #decriminalize drug possession in Oregon with a Portugal-inspired approach.
3
86
332
7
58
367
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
If we do succeed with our second Phase 3 study of MDMA-assisted therapy for PTSD, the whole field of psychedelic psychotherapy will have been proven in one instance, serving as the pathbreaker with the FDA. @MAPS @TODAYShow @NBC @SavannahGuthrie @JonLubecky
@MAPS
MAPS
3 years
MAPS is on The @TODAYShow ! We are excited to see the results of MAPS-sponsored research reaching mainstream audiences as we continue to advocate for increased access to #psychedelic therapy. Watch @NBC 's interview with MAPS Founder @RickDoblin , Ph.D.:
Tweet media one
1
56
138
10
99
360
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
Paired with his audacious dedication to humanizing people who use drugs, @DrCarlHart challenges the fear-based dogmas of the War on Drugs. Welcome to the @MAPS Board of Directors, Carl!
@MAPS
MAPS
3 years
MAPS is honored to announce the election of @DrCarlHart to our Board of Directors! Dr. Hart's decades of experience have compelled him to examine how the #WarOnDrugs has shaped and reinforced global structural inequities. Join us in welcoming Dr. Hart!
Tweet media one
12
49
317
8
38
338
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
It’s my pleasure to share the most important research update that has ever taken place in @MAPS ’ 31-year history:
@MAPS
MAPS
7 years
FDA Grants Breakthrough Therapy Designation for #MDMA -Assisted Psychotherapy for #PTSD @US_FDA #Science #Psychedelic
Tweet media one
21
282
522
19
167
299
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
On August 16, 2017, the FDA designated MDMA-assisted psychotherapy for PTSD as a Breakthrough Therapy.
13
125
292
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
Today is my 64th birthday! What a great time to be alive—we’re witnessing the revival of psychedelic research, the turning of the tide for marijuana prohibition, and MDMA is on the way to becoming a legal prescription medicine.
Tweet media one
40
59
300
@RickDoblin
Rick Doblin, Ph.D., of MAPS
9 years
I’m speaking on the @JoeRogan Experience podcast on April 7 to talk about the current state of @MAPS ' psychedelic research program!
9
85
289
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
Wow! What a special moment it was when I discovered that I reached 50K followers on Twitter! Thank you for being here, expressing interest in my life's work, and supporting our team at @MAPS at this critical moment in our 36-year history.
11
9
291
@RickDoblin
Rick Doblin, Ph.D., of MAPS
5 years
Pioneering psychedelic researcher and spiritual teacher Baba Ram Dass, born Richard Alpert, passed away on Sunday, December 22, 2019. Ram Dass was a great inspiration to thousands/millions of people including me.
Tweet media one
5
50
284
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
It’s not the drug — it’s the therapy enhanced by the drug.
@MAPS
MAPS
3 years
Soon to be published in @NatureMedicine , the first completed MAPS-sponsored Phase 3 clinical trial of #MDMA -assisted #therapy for #PTSD shows positive peer-reviewed results, marking a historic point in the field of #psychedelic science. via @NYTimes
0
60
200
8
48
275
@RickDoblin
Rick Doblin, Ph.D., of MAPS
5 years
We commend FDA for recognizing the great unmet medical need of PTSD by allowing access to MDMA-assisted psychotherapy on a compassionate basis for people with treatment-resistant PTSD. We are delighted to begin generating real-world evidence about this potential new treatment.
@MAPS
MAPS
5 years
Today, MAPS is announcing that the U.S. Food and Drug Administration (FDA) has agreed to MAPS’ application for an #ExpandedAccess program for #MDMA -assisted #psychotherapy for #PTSD , which will allow 50 patients to receive MDMA-assisted #psychotherapy .
22
241
708
11
49
267
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
Prior Positive Results Confirmed in @MAPS -Sponsored, Philanthropy-Funded Phase 3 Trial Today, we can imagine that MDMA-assisted therapy for PTSD may soon be available and accessible to all who could benefit.
Tweet media one
16
60
261
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
At 36, @MAPS is now older than I was when I started MAPS at age 32. Personally, it's been a blessing to see so much progress and healing in my own lifetime. From all of us at MAPS, thank you so much for helping us move closer to making legal psychedelic medicine possible!
@MAPS
MAPS
3 years
Happy 36th anniversary to us! On April 8, 1986, MAPS was founded by @RickDoblin , Ph.D. Today, we are closer than ever to legalizing #MDMA -assisted therapy for PTSD, though there is still a long road ahead. Celebrate our anniversary with a gift to MAPS:
Tweet media one
3
24
64
10
31
253
@RickDoblin
Rick Doblin, Ph.D., of MAPS
6 years
After 32 years of hard work, @MAPS is about to begin Phase 3 clinical trials of MDMA-assisted psychotherapy for PTSD. Donate today and your donation will be doubled:
8
80
238
@RickDoblin
Rick Doblin, Ph.D., of MAPS
5 years
As I celebrate my 66th birthday today, I reflect on the gift of generous support throughout the years from family, friends, colleagues, and the psychedelic community. Thank you!
@MAPS
MAPS
5 years
Happy 66th birthday to MAPS Founder and Executive Director @RickDoblin , Ph.D.! Today, we celebrate Rick’s leadership, achievements, and over 33 years of dedication to expanding #psychedelic science and medicine. Give Rick a #birthday gift: #HappyBirthday
Tweet media one
3
30
142
23
14
245
@RickDoblin
Rick Doblin, Ph.D., of MAPS
6 years
I am honored to announce that Business Insider has named me one of the top ten people transforming healthcare!
@MAPS
MAPS
6 years
. @BusinessInsider names MAPS Founder @RickDoblin , Ph.D., one of the 10 leaders transforming #healthcare . Doblin stands out for the progress he's made towards changing the field of #MentalHealth care through studies of #MDMA -assisted #psychotherapy .
Tweet media one
0
26
73
9
32
240
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
We’re witnessing the turning of the tide for marijuana prohibition. #NoMoreDrugWar #DrugPolicyReform
12
63
219
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
We think it’s going to require a decade of psychedelic clinics being rolled out for people to hear about the positive experiences. We’ll have licensed legalization, I think, in 2035.
@MAPS
MAPS
3 years
#Harvard Law Today covers the launch of the Project on #Psychedelics Law and Regulation (POPLAR) at @Harvard_Law School's @PetrieFlom Center for Health Law Policy, Biotechnology, and Bioethics. Check out the event highlights and recordings!
1
28
79
14
52
222
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
Thank you, @LisaLing , for inviting me to discuss psychedelic therapy on @CNN ! Watch the new episode of This is Life on Sunday at 10:00 PM (EST/PST):
Tweet media one
7
28
210
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
As a result of this study and through the persistent and consistent application of scientific rigor, we have demonstrated that MDMA-assisted therapy is likely to provide relief for people diagnosed with PTSD.
@MAPS
MAPS
3 years
The first Phase 3 trial of #MDMA -assisted therapy for posttraumatic stress disorder ( #PTSD ) replicated and expanded on Phase 2 results indicating MDMA-assisted #therapy may be an effective and cost-saving treatment for PTSD resulting from any cause. (1/6)
Tweet media one
2
49
158
6
51
204
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
It was great to sit down with @JoeRogan for my third appearance on the #JoeRoganExperience . Amazingly, we did the interview without smoking marijuana! In the podcast, we discuss the successes and challenges of @MAPS ' work in the psychedelic field.
13
37
194
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
The successful completion of two Phase 3 studies for PTSD gives us hope for MDMA-assisted therapy & all #psychedelics . The #psychedelic movement is expanding & building community at @PsychedelicSci ! Join us from June 19-23 in Denver
17
40
175
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
In one small example of retaining the soul of @MAPS , I’m happy to report that our employment manual includes a concept called "smokable tasks." These are work tasks that a staff member does better while under the influence of marijuana!
@MAPS
MAPS
3 years
"We’re passionately committed to retaining our soul as we develop a larger corporate structure." — @RickDoblin , Ph.D., MAPS Founder and Executive Director Read Doblin's full update in the latest edition of the #MAPSBulletin :
Tweet media one
1
8
39
7
30
199
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
@tferriss @michaelpollan @Drug_Researcher @RCarhartHarris @tferriss : @MAPS has recently engaged patent attorneys to assist in strengthening our anti-patent strategy for uses of MDMA, and to prepare easily accessible information for patent examiners so patents will not be issued in the first place.
Tweet media one
8
29
186
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
@elonmusk @insidepharma @jimcramer At the non-profit @MAPS , we have a plan to bring MDMA-assisted therapy to millions in need. We can achieve it with $150M over three years ($50M/year) in donations from our generous supporters. Let me know if you’d like to connect, @ElonMusk .
5
29
187
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
In MDMA-assisted therapy, the treatment is not the drug—the drug is just a tool. It's the relationship that we have with it that makes the difference. Listen to the full episode of the Bialik Breakdown with @MissMayim Bialik:
5
35
176
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
The results of the interim analysis of MAPS’ pivotal first Phase 3 trial are the most powerful evidence yet that MDMA-assisted psychotherapy could help transform the lives of people suffering from PTSD.
@MAPS
MAPS
4 years
Today, the non-profit MAPS announced the results of an interim analysis of the #data from the first of its two Phase 3 #ClinicalTrials of #MDMA -assisted #psychotherapy for posttraumatic stress disorder ( #PTSD ).
Tweet media one
10
79
203
5
67
168
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
Now streaming: @Netflix 's "How to Change Your Mind” series!   Based on the book by @MichaelPollan , Chapter 3: #MDMA spotlights MAPS’ #psychedelic research with MDMA-assisted therapy. Help change minds by spreading awareness!
@MAPS
MAPS
2 years
Now streaming: @Netflix 's "How to Change Your Mind” series!   Based on the book by @MichaelPollan , Chapter 3: #MDMA spotlights MAPS’ #psychedelic research with MDMA-assisted therapy. Help change minds by spreading awareness!
Tweet media one
9
109
310
15
35
166
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
MDMA was a therapy drug before it became a party drug. Last night, I joined @FoxBusiness ' Kennedy to discuss @MAPS ' efforts to bring MDMA back to therapy. Thanks for your support of MAPS, @KennedyNation ! We hope to see you at @PsychedelicSci 2023.
8
36
158
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
The Pineapple Fund's outstanding generosity exemplifies how the growth of cryptocurrency can be leveraged for profound social change. The blockchain community is helping to lead the way in giving the gift of MDMA-assisted psychotherapy to the world in order to heal trauma.
@MAPS
MAPS
7 years
Yesterday, the Pineapple Fund donated 59.89 #Bitcoin (BTC), with a value of $1,000,000, to the Multidisciplinary Association for #Psychedelic Studies ( @MAPS ). We are thankful and inspired by the #PineappleFund 's plan to #donate over $86 million in #BTC .
Tweet media one
8
42
161
3
67
154
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
Wellness check results are in: alive and well! Working hard with the @MAPS team to make MDMA a medicine. I hope that our work toward reducing the stigma surrounding psychedelics inspires you to help reduce the stigma about offices like mine, @RateMySkypeRoom !
@ratemyskyperoom
Room Rater
2 years
Never would’ve guessed this is the result of 3 decades of psychedelic research/advocacy. Requesting a wellness check. (Not rated) @RickDoblin
Tweet media one
10
7
80
9
21
158
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
In @CrookedMedia 's Lovett or Leave It podcast, @JonLovett and I have a lively discussion about the history of MDMA, @MAPS ' recent MDMA/PTSD research, and how society can achieve mass mental health through a system of licensed legalization for all drugs.
@CrookedMedia
Crooked Media
3 years
Psychedelics as medicine? @jonlovett discusses with Dr. @RickDoblin , founder and executive director @MAPS .
7
19
141
6
24
155
@RickDoblin
Rick Doblin, Ph.D., of MAPS
8 years
I'm in D.C. to testify about MDMA sentencing guidelines, which currently sit at a 500:1 sentencing disparity between MDMA and marijuana.
9
38
141
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
Many thanks to @LexFridman for hosting me on his podcast! Listen as we have an excellent conversation about the history of psychedelics in culture and research, the ways in which @MAPS is working to shape the future of psychedelics, and much more.
12
20
147
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
These long-term follow-up findings show that once people with PTSD learn that they can productively process traumatic memories instead of suppressing them, they can continue to heal themselves even after they have stopped receiving MDMA-assisted psychotherapy.
@MAPS
MAPS
4 years
Today, the non-profit MAPS announced the #publication of the long-term follow-up results of six Phase 2 #ClinicalTrials of #MDMA -assisted #psychotherapy for the treatment of #PTSD in the peer-reviewed journal Psychopharmacology. #PressRelease
Tweet media one
8
77
173
7
45
147
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
Explore the resurgence of psychedelic research, including @MAPS -sponsored clinical trials of MDMA-assisted therapy for PTSD, in a new @PBS program! Now streaming on @NOVAPBS , YouTube, and the PBS Video app.
Tweet media one
Tweet media two
7
34
140
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
Psychedelics are not producing unique psychedelic experiences; they are producing human experiences mediated by psychedelics.
@MAPS
MAPS
4 years
Listen to MAPS Founder and Executive Director @RickDoblin , Ph.D., describe the therapeutic potential of #psychedelics and convey the importance of #PsychedelicResearch in ABC @RadioNational 's All in the Mind #podcast with @LynneMalcolm .
Tweet media one
1
9
39
5
35
137
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
The blockchain community is helping to lead the way, not only in decentralized technologies and currencies, but in giving the gift of MDMA-assisted psychotherapy to the world in order to heal trauma and bring greater compassion to psychiatry and medicine.
2
38
136
@RickDoblin
Rick Doblin, Ph.D., of MAPS
8 years
A great read which I recommend to anyone interested in the spiritual aspects of the psychedelic experience
Tweet media one
4
44
136
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
At last year's World Economic Forum ( @WEF ) in Davos, I forecast the future of psychedelic legalization. Through our work at @MAPS , I predict that there will be thousands of psychedelic clinics and enhanced access to psychedelics in the next decade.
8
28
132
@RickDoblin
Rick Doblin, Ph.D., of MAPS
8 years
By ending marijuana prohibition, we will be able to conduct rigorous scientific studies into the risks and benefits of this plant.
4
59
126
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
We can now truly say that #MDMA -assisted psychotherapy will be a gift to the world from the #psychedelic and #cryptocurrency communities, with @MAPS having been unable to obtain any government funding for our research.
@MAPS
MAPS
7 years
Today, @MAPS is proud to announce the successful completion of the $4 million matching grant from the #PineappleFund for @US_FDA Phase 3 clinical trials of #MDMA -assisted psychotherapy for #PTSD . Thank you to everyone who donated!
Tweet media one
5
46
142
6
34
132
@RickDoblin
Rick Doblin, Ph.D., of MAPS
8 years
After almost four years, we’re just 3 weeks away from Psychedelic Science 2017! So much to learn about new research from around the world.
4
24
124
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 months
In challenging times, we are reminded of the importance of gathering in community. Next week, I'll be in Black Rock City for @BurningMan , and I hope to see you there! Image by @Nirvan for @WhatATripFilm
Tweet media one
Tweet media two
16
8
108
@RickDoblin
Rick Doblin, Ph.D., of MAPS
8 years
Amazing, Psychedelic Science 2017 will be the largest conference about psychedelics ever with attendance of 2300+! The time is right.
0
28
120
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
It is a fundamental violation of #HumanRights to block access to drugs that change people's #consciousness . We should be regulating people's behaviors, not their thoughts. Or their feelings.
@MAPS
MAPS
4 years
Read the Sarasota @HeraldTribune 's front-page profile of MAPS Founder and Executive Director @RickDoblin , Ph.D., which outlines Doblin's founding of MAPS and research updates from the #psychedelic renaissance. Article: @BilleeCox Image: @GregoryBull / @AP
Tweet media one
0
9
43
5
28
116
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
The overall goal is to have a more spiritualized humanity that can, instead of fighting each other, address our common challenges, such as climate change and the rise of authoritarianism. via @BulletinAtomic / @RobertKElder
@BulletinAtomic
Bulletin of the Atomic Scientists
3 years
Rick Doblin and Carol Rosin gave MDMA to Soviet scientists and military personnel set to negotiate with US President Ronald Reagan in 1985. Even now, they still believe introducing psychedelics in nuclear talks can produce positive results.
2
14
38
3
32
113
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
@C_Angermayer @tferriss @michaelpollan @RCarhartHarris As @C_Angermayer notes, easier access to capital is a key advantage of for-profit psychedelic drug development over non-profit drug development reliant on philanthropy. However, Christian is not correct that patents are essential to obtain exclusive rights to market a medicine.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
6
25
113
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
Thanks for following @MAPS on social media! #FollowFriday
6
14
115
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
I look forward to speaking in the sixth and final session of @PennNursing 's psychedelic education series on March 30. Attend one or more sessions in this free series to expand your psychedelic knowledge! The series begins on January 19.
@PennNursing
Penn Nursing
3 years
Kick off the new year by joining us for a free, virtual learning series on psychedelics. The first event takes place on January 19 with an introduction to psychedelics, including historical roots and their emergence into Western medicine. Learn more: .
Tweet media one
0
16
55
1
25
111
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
"So where did this research suddenly come from?" asks Paul Frysh of @WebMD . There's nothing sudden about it! The promise was all there in the psychedelic research from the '50s and '60s—all you had to do was look. Explore @WebMD 's psychedelic series:
@MAPS
MAPS
3 years
Top healthcare site @WebMD publishes a multi-part series about #psychedelic -assisted #therapy ! Explore this series for an overview of current #research , perspectives from experts in the field including @RickDoblin , Ph.D., and psychedelic FAQs. (1/3)
1
29
73
3
25
110
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
@C_Angermayer @tferriss How do you justify decriminalization but not legalization?
Tweet media one
Tweet media two
Tweet media three
Tweet media four
7
22
113
@RickDoblin
Rick Doblin, Ph.D., of MAPS
6 years
My new article for @TIME covers how U.S. and global drug prohibition has, for decades, delayed medical research into the healing properties of Schedule 1 drugs.
3
53
108
@RickDoblin
Rick Doblin, Ph.D., of MAPS
5 years
Today is the 34th anniversary of the history of MAPS! I can only be delighted to think about what's going to happen in the next 34 years. Join me at 4:20 ET for a live stream Q&A on the MAPS Facebook page!
@MAPS
MAPS
5 years
Today is MAPS' 34th anniversary! April 8, 1986, MAPS was founded as a non-profit #psychedelic research and #educational organization by @RickDoblin , Ph.D. Join the #LiveStream Q&A session today at 4:20 PM Eastern with Rick Doblin on our Facebook page.
0
22
90
4
14
110
@RickDoblin
Rick Doblin, Ph.D., of MAPS
6 years
I started MAPS in 1986 as a non-profit psychedelic pharmaceutical company with the goal of making MDMA a prescription medicine. If we can get a fair amount of donations, we may be able to make MDMA-assisted psychotherapy for PTSD a legal treatment by 2021.
@MAPS
MAPS
6 years
MAPS is a non-profit organization seeking donations to develop #medical contexts for #psychedelics and #marijuana . Donate today to support mental #health research:
14
112
242
1
38
104
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
I recently had prostate cancer surgery. Early detection & advanced technology led to my positive outcomes with no evidence of spread, allowing me to continue mainstreaming psychedelics with @MAPS ! I encourage everyone to pursue regular cancer screening.
8
5
107
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
Common Ground Magazine interviewed me about the past 30 years of psychedelic research
Tweet media one
0
28
107
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
In a step towards the destigmatization of psychedelics, U.S. Army SGT(R) @JonLubecky of @MAPS and I attended @RepDanCrenshaw 's Healthcare Innovation Summit to discuss the groundbreaking, nonpartisan psychedelic research conducted by MAPS. Watch:
Tweet media one
16
18
104
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 months
I'd like to wish a Happy Birthday to Stanislav Grof, one of my mentors who has taught me valuable lessons about psychedelics, therapy, and nonordinary states of consciousness. His research has laid the foundation for much of my work @MAPS and the field writ large.
0
13
103
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
We are in the middle of a renaissance in psychedelic research and I think it's been a pleasure to really devote myself to this.
@MAPS
MAPS
7 years
#Psychedelic Therapy Goes Mainstream: Rick Doblin Interview via @VintheD @RickDoblin @BreakingCon #Psychedelics
Tweet media one
2
13
38
4
18
94
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
There's a lot of work to be done to build a psychedelic-informed culture—it will take decades.
@MAPS
MAPS
3 years
In an interview with @SkipperClay of @GQMagazine , MAPS Founder and Executive Director @RickDoblin , Ph.D., discusses the origins of MAPS, his personal experience with #psychedelics , and a future society in which psychedelics are responsibly integrated.
3
10
62
6
15
90
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
The completion of data gathering in our second Phase 3 study of MDMA-assisted therapy for PTSD is a critical milestone in @MAPS ’ 36-year campaign to obtain FDA approval for the therapeutic use of MDMA. (1/2)
@MAPS
MAPS
2 years
MAPS is proud to share MAPS Public Benefit Corporation's announcement that the final participant in the second Phase 3 trial of #MDMA -assisted therapy completed their final session in the clinical trial treatment protocol.
Tweet media one
11
23
92
8
17
91
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
. @MAPS and I are looking forward to this significant expansion of psychedelic education into the mainstream! Save the date for the @Netflix series debut on Tuesday, July 12. #HowToChangeYourMind @MichaelPollan
@MAPS
MAPS
2 years
MAPS is excited to take center stage in an episode of the highly anticipated @Netflix series #HowToChangeYourMind based on the best-selling book by @MichaelPollan ! Watch the trailer and mark your calendar for the series debut on Tuesday, July 12.
9
134
362
2
19
92
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
Completion of the Phase 3 trials, made possible by generous donors to the $30 million Capstone Campaign, is a crucial moment in the potential approval of what may soon be the first broadly legal psychedelic-assisted therapy.
@MAPS
MAPS
4 years
MAPS and the #Psychedelic Science Funders Collaborative (PSFC) today announced the completion of the Capstone Campaign, a non-profit fundraising effort to fund the final research required to seek U.S. FDA approval of #MDMA -assisted psychotherapy for #PTSD .
Tweet media one
8
63
177
2
19
91
@RickDoblin
Rick Doblin, Ph.D., of MAPS
5 years
It is my sincere delight to introduce to our MAPS community, Ana LaDou, MAPS’ new Chief Operating Officer (COO). We are thrilled to have Ana join the team at MAPS, bringing with her almost two decades of experience in nonprofit leadership.
Tweet media one
2
8
90
@RickDoblin
Rick Doblin, Ph.D., of MAPS
9 years
Why America Needs an FDA for Recreational #Drugs - http://t.co/e6KNbQscOL via @VICE @maiasz #Politics
0
68
55
@RickDoblin
Rick Doblin, Ph.D., of MAPS
8 years
I had a great time talking with @ChelseaHandler about psychedelics and @MAPS on @ChelseaShow !
Tweet media one
4
14
79
@RickDoblin
Rick Doblin, Ph.D., of MAPS
6 years
In 2019, more scientific research will be happening into the therapeutic uses of psychedelic compounds than at any time in history. via @StatNews
0
25
84
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
In my early twenties, I was trying to get to the core self without all of the compromises of civilization when I started raising a wolf cub named Phaedrus. It was great to speak with Sarah Rose Siskind ( @SRSiskind ) about this experience!
6
19
79
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
Thanks to Walter Reed National Military Medical Center ( @WRBethesda ) for hosting me at yesterday's Grand Rounds. I was pleased to present about @MAPS -sponsored research of MDMA-assisted therapy for PTSD to an audience of military psychiatrists and psychotherapists.
Tweet media one
3
12
74
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
On my birthday today, I am feeling so grateful for everyone who has supported @MAPS and me over the years. To celebrate my 69th birthday, consider donating $69+ to MAPS. Using this link, you might even win a prize—more details on @MAPS ' profile later!
11
8
78
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
Follow along with @MAPS as we prepare to celebrate our 35th anniversary in 35 days! Between now and April 8, the day I founded MAPS in 1986, MAPS is sharing highlights from each year of its psychedelic history.
@MAPS
MAPS
4 years
#MAPS35 : As we approach our 35th #anniversary on April 8, we are sharing highlights from each year of MAPS’ #history ! In 1986, @RickDoblin founded MAPS as an official 501(c)(3) #NonProfit . Later that year, Doblin sued the DEA for the first time.
Tweet media one
Tweet media two
Tweet media three
Tweet media four
1
13
74
4
9
81
@RickDoblin
Rick Doblin, Ph.D., of MAPS
6 years
A #psychedelic experience helps because you get deeper insight, you let certain emotions rise closer to the surface. #MentalHealth #PsychedelicTherapy @Playboy
Tweet media one
1
19
78
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
It’s profoundly satisfying to see this occurring, about half a century after the backlash to the psychedelic 1960s and the criminalization, stigmatization, exaggerated risk estimates, and suppression of research into benefits that followed.
@MAPS
MAPS
7 years
"These days, I increasingly smile at how mainstream #psychedelic -assisted psychotherapy is becoming." — @MAPS Founder @RickDoblin .
3
27
104
4
21
82
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
When I started @MAPS in 1986, there was no government funding for this research. Psychedelic research was still completely shut down. See how far we've come in this new video from @BBC_Reel !
@MAPS
MAPS
2 years
In a new 10-minute @BBC_Reel documentary, @BBC explores the potential of psychedelic-assisted therapy and MAPS Founder @RickDoblin , Ph.D., shares perspective about MAPS-sponsored research of #MDMA -assisted therapy for the treatment of PTSD.
1
38
110
5
18
80
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 months
Our psychedelic work continues.
@MAPS
MAPS
2 months
A Message from our founder, @RickDoblin : FDA Decision, Redoubling of MAPS Efforts, Lykos Board Resignation. These have been very challenging times at MAPS, at Lykos, in the entire psychedelic ecosystem, and in the world at large. This moment is sobering, yet it anchors me and
Tweet media one
Tweet media two
Tweet media three
Tweet media four
12
9
85
0
9
82
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
Happy New Year, everyone! In the many days ahead of 2023, what can we do to strengthen the foundations of this movement towards healing?
15
8
73
@RickDoblin
Rick Doblin, Ph.D., of MAPS
1 year
The Future of Psychedelics: Drug Development & Policy Reform My psychedelic talk has the chance to hit the stage at @SXSW 2024, and community support can make it happen. Cast your vote on #SXSW PanelPicker before August 20!
Tweet media one
25
14
54
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
We are bringing people together from all over the world who are interested in #psychedelics for @PsychedelicSci ! Join @MAPS and the psychedelic community at #PS2023 from June 19-23, in Denver, CO:
4
14
69
@RickDoblin
Rick Doblin, Ph.D., of MAPS
4 years
I am grateful for the long-term strategic and philanthropic support that MAPS has received from David Bronner and the Bronner family. The support MAPS has received is pivotal to our ability to gather data on MDMA-assisted psychotherapy for PTSD.
@MAPS
MAPS
4 years
MAPS Founder @RickDoblin , Ph.D., reflects on MAPS' 34 years of #psychedelic research and @DrBronner 's contributions to MAPS' mission through the Heal Soul campaign and beyond.
0
14
50
3
6
74
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
. @MAPS ' research of MDMA-assisted therapy for PTSD will be featured in a psychedelic-focused @NOVAPBS program! Catch the premiere this Wednesday, October 19, at 9:00 PM (ET).
Tweet media one
2
16
69
@RickDoblin
Rick Doblin, Ph.D., of MAPS
7 years
We're inspired and deeply grateful to the Mercer Family Foundation for their commitment to America's veterans and to the field of psychedelic science. They are to be commended for their gift.
@MAPS
MAPS
7 years
PRESS RELEASE: Mercer Family Foundation Grants $1 Million to @MAPS for #PTSD Research in #Veterans
10
39
98
6
17
76
@RickDoblin
Rick Doblin, Ph.D., of MAPS
9 years
Looking at the preliminary data, I’m more confident than ever that MDMA-assisted psychotherapy will soon be a legal medicine.
2
39
73
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
Psychedelic Therapy Is Poised to Create a Revolution in Mental Health, Can VR Accelerate It? via @Forbes / @NeoPharmaco
4
12
73
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
Listen to my recent appearance on the @AubreyMarcus Podcast to understand @MAPS ' multiple research, policy, and education priorities in the context of our larger, long-term goal of mass mental health!
3
22
75
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
A profound focus on methodology will anchor what we’re doing going forward without this historical backlash against psychedelics.
@MAPS
MAPS
3 years
"Since 1966, the National Institutes of Health has only funded #psychedelic research in very limited capacities, making organizations like MAPS, which solicits donations for research, even more important." via @TheCrimson
0
10
38
6
9
70
@RickDoblin
Rick Doblin, Ph.D., of MAPS
6 years
Thank you to everyone in the MAPS community who helped us raise $386,140 for our year-end fundraising campaign! With the continued support of MAPS donors, I am confident that this year will be even more astonishing than last year.
@MAPS
MAPS
6 years
Thank you to our #community for the inspiring abundance of gifts to our year-end fundraising #campaign ! A total of 1,875 #donors from 43 countries contributed $386,140, reaching 129% of our initial $300,000 year-end fundraising goal.
Tweet media one
4
9
32
2
15
73
@RickDoblin
Rick Doblin, Ph.D., of MAPS
8 years
Psychedelics have been tremendously beneficial to me and to loads of people that I know.
@MAPS
MAPS
8 years
. @MAPS Founder @RickDoblin discusses the integration of therapeutic #psychedelic experiences via @Killing_Buddha
2
10
33
2
17
66
@RickDoblin
Rick Doblin, Ph.D., of MAPS
8 years
I’ve always known MDMA would work, but it’s been really gratifying to see such tremendous results. @Guardian
1
45
69
@RickDoblin
Rick Doblin, Ph.D., of MAPS
6 years
FDA approval of whole plant medical marijuana would mean that patients could have their medical marijuana covered by insurance, although that possibility is currently blocked by the Department of Justice-enforced NIDA monopoly on marijuana for research.
2
28
66
@RickDoblin
Rick Doblin, Ph.D., of MAPS
3 years
Listen to the @Drug_Science Podcast, where I speak with @ProfDavidNutt about @MAPS ' 35-year history, current project updates, and future vision for the next 35 years of psychedelic progress.
@Drug_Science
Drug Science
3 years
🎙️✨ In this BRAND NEW episode of the #DrugSciencePodcast , @RickDoblin and @ProfDavidNutt attempt to summarise 35 years of MDMA #research in 50 minutes! How did they do? 🤔 🎧 Listen to the full #podcast at: @MAPS @MAPSCanada
2
18
29
1
22
71
@RickDoblin
Rick Doblin, Ph.D., of MAPS
2 years
At this moment, when MDMA-assisted therapy for PTSD is closer to potential FDA approval than ever before, @MAPS and MAPS PBC must faithfully retain our values against the sometimes diametric values of the systems in which we operate. @Psyched_Alpha
3
8
61